Pregled bibliografske jedinice broj: 409818
Synthesis and Biological Activity of Novel Pyrimidine Derivatives
Synthesis and Biological Activity of Novel Pyrimidine Derivatives // XXI. Hrvatski skup kemičara i kemijskih inženjera, Knjiga sažetaka / Pičuljan, Katarina ; Smolec, Sonja (ur.).
Zagreb: Hrvatsko društvo kemijskih inženjera i tehnologa (HDKI) ; Hrvatsko kemijsko društvo, 2009. str. 104-104 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 409818 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Synthesis and Biological Activity of Novel Pyrimidine Derivatives
Autori
Saftić, Dijana ; Žakić, Željka ; Župančić, Nataša ; Glavaš-Obrovac, Ljubica ; Žinić, Biserka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
XXI. Hrvatski skup kemičara i kemijskih inženjera, Knjiga sažetaka
/ Pičuljan, Katarina ; Smolec, Sonja - Zagreb : Hrvatsko društvo kemijskih inženjera i tehnologa (HDKI) ; Hrvatsko kemijsko društvo, 2009, 104-104
ISBN
978-953-6894-38-3
Skup
XXI. Hrvatski skup kemičara i kemijskih inženjera
Mjesto i datum
Trogir, Hrvatska, 19.04.2009. - 22.04.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
5-Fluorouracil; N-Sulfonyl Derivatives; Reversed Nucleosides
Sažetak
As a part of our research program on the synthesis of novel sulfonylurea derivatives as potential anticancer agents, and reversed nucleosides as a starting material for the synthesis of optically active aliphatic and "double headed" nucleoside analogues, we synthesized 1-sulfonylpyrimidine derivatives and reversed nucleosides. The synthesis involved the condensation of silylated pyrimidine bases with aryl, heterocyclic or aliphatic sulfonyl chlorides or reaction of the pyrimidine bases with sulfonyl chlorides or activated sugar derivative in the presence of potassium carbonate, sodium hydride or triethylamine. New derivatives were tested for their antiproliferative effects using 7 different human tumor cell lines (HeLa, HEp-2, MIAPaCa2, Caco2, SW620, MCF-7, and NCI-H358) and human fibroblasts (WI38) in a parallel with 5-fluorouracil, as a standard antitumor drug. Cell lines were incubated with four 10-fold dilutions (10-8 to 10-4 M). After 72 hours of incubation, the cell growth rate was evaluated using the MTT assay. The tested compounds inhibited the growth of different tumor cell lines with varying IC50 values (>100 to 2 μ M). In comparison with 5-fluoruracil, all investigated compounds are significantly less cytotoxic on human fibroblasts.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Projekti:
098-0982914-2935 - Sinteza novih biološki aktivnih derivata nukleobaza i nukleotida (Žinić, Biserka, MZOS ) ( CroRIS)
219-0982914-2176 - Mehanizam bioloških učinaka novih malih molekula na stanice tumora čovjeka (Glavaš Obrovac, Ljubica, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Željka Ban
(autor)
Biserka Žinić
(autor)
Dijana Pavlović Saftić
(autor)
Ljubica Glavaš Obrovac
(autor)